11 Revived Stocks That Traded For $5 Or Less Are Now Worth BillionsInvestors Business Daily • 08/04/23
Roivant Surges As Roche Reportedly Considers $7 Billion Drug TakeoverInvestors Business Daily • 07/14/23
Acadia stock rallies on drug news as Roivant also climbs, while Leslie's, Theseus shares plunge and more moving stocksMarket Watch • 07/14/23
Roivant Sciences' RVT-3101: Advancing Ulcerative Colitis Treatment InnovationSeeking Alpha • 07/10/23
Roivant Sciences Ltd. (ROIV) Surges 8.9%: Is This an Indication of Further Gains?Zacks Investment Research • 07/06/23
After ‘transformative' year, Roivant aims to challenge bigger rivals in inflammation and immunologyMarket Watch • 06/28/23
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 06/28/23
UPDATE -- Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business UpdateGlobeNewsWire • 06/28/23
Roivant Sciences' stock up 3.7% premarket after posting narrower-than-expected lossMarket Watch • 06/28/23
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business UpdateGlobeNewsWire • 06/28/23
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provide Business Update on Wednesday, June 28, 2023GlobeNewsWire • 06/26/23
A First-Ever In Ulcerative Colitis Sends Roivant Stock Into A BreakoutInvestors Business Daily • 06/22/23